Infections

All Conditions

Ear, Nose, and Throat Diseases

Nervous System Diseases

Symptoms and General Pathology

Respiratory Tract (Lung and Bronchial) Diseases

Urinary Tract, Sexual Organs, and Pregnancy Conditions

Rare Diseases

Hearing Loss

Deafness

Communicable Diseases

Post-Acute COVID-19 Syndrome

Papillomavirus Infections

Rhinosinusitis

Otorhinolaryngologic Diseases

Sinusitis

Syndrome

COVID-19

Rhinitis

Respiratory Tract Infections

Paranasal Sinus Diseases

Nose Diseases

Respiratory Tract Diseases

Pneumonia

Pneumonia, Viral

Virus Diseases

Coronavirus Infections

Coronaviridae Infections

Nidovirales Infections

RNA Virus Infections

Lung Diseases

Post-Infectious Disorders

Chronic Disease

Disease Attributes

Sexually Transmitted Diseases

Sexually Transmitted Diseases, Viral

DNA Virus Infections

Tumor Virus Infections

Genital Diseases

Urogenital Diseases

Chronic Graft Versus Host Disease

Acute Graft Versus Host Disease

Emanuel Maitz, MD

Reinhard Domanyi, MD

The aim of the present study will be to evaluate in conscripts at the military induction board the prevalence of rhinosinusitis, the prevalence of HPV vaccinations, the prevalence of hearing impairments and the prevalence of long-COVID symptoms and further, to evaluate different factors that influence on the one hand the prevalence (urban-bred, non-urban-bred) and on the other hand symptoms (ENT-surgeries in medical history). Further, we want to evaluate if there is a correlation between subjective symptoms and apparated-based diagnostic investigations.

Therefore, questionnaires and data of medical examinations, aquired routinely at the military induction board, will be analysed.

Rhinosinusitis is a very common complaint at ENT departments, whereby symptoms of the underlying disease are varying. Therefore, there is growing interest in prevalence of rhinosinusitis including differences in prevalence's depending on where the patient grew up. Further, there is growing interest in answering the question if different factors, including ENT-surgeries in medical history have an impact on symptoms of rhinosinusitis.

Within the past few years there is growing interest in carring out as many HPV-vaccinations as possible in order to reduce the prevalence of HPV-associated cancers.

Further, in adolescents there is a growing number of hearing impairments, including hearing loss and/or sounds in the ears.

Next, since the beginning of the COVID pandemic there are very common complaints in adult and pediatric patients about persistent medical problems for weeks or months after an acute SARS-CoV-2-infection and cannot be explained by another diagnosis, called long- Covid disease.

The military induction board of conscripts enables access to data from a cross-section of the population, with common characteristics of gender and age.

In the present study we want therefore to evaluate in conscripts at the military induction board the prevalence of rhinosinusitis, the prevalence of HPV vaccinations, the prevalence of hearing impairments and the prevalence of long-COVID symptoms and further, to evaluate different factors that influence on the one hand the prevalence (urban-bred, non-urban-bred) and on the other hand symptoms (ENT-surgeries in medical history). Further, we want to evaluate if there is a correlation between subjective symptoms and apparated-based diagnostic investigations.

only Austrian males (conscripts), who are invited at the military induction board

Prevalence of ENT Diseseas

Prevalence Study of ENT-related Diseases in Conscripts at the Military Induction Board

To assess whether there is a difference in prevalence of rhinosinusitis in urban-bred conscripts compared to non-urban-bred conscripts.

To assess whether there is a difference in prevalence of human papilloma virus vaccinations in urban-bred conscripts compared to non-urban-bred conscripts.

To assess whether there is a difference in prevalence of hearing impairment in urban-bred conscripts compared to non-urban-bred conscripts.

To assess whether there is a difference in prevalence of long-COVID disease in vaccinated conscripts compared to no-vaccinated conscripts.

To assess prevalence of rhinosinusitis in conscripts at the military induction board

To assess the different symptoms of rhinosinusitis in conscripts at the military induction board

To assess the prevalence of rhinosinusitis in conscripts with previous ENT-surgeries

To assess differences in symptoms in rhinosinusitis in conscripts with previous ENT-surgeries

To assess the combined prevalence of rhinosinusitis and chronic pulmonary diseases in conscripts

To assess the difference in prevalence of subjective symptoms of rhinosinusitis compared to objective (apparatus based and laboratory based) symptoms of rhinosinusitis

To analyse demographic data in conscripts with rhinosinusitis

To assess the prevalence of HPV vaccines among conscripts at the military induction board

To assess knowledge about HPV and HPV vaccinations and in dependent of that prevalence of HPV vaccines among conscripts at the military induction board

To assess the prevalence of hearing impairment in conscripts at the military induction board

To assess the difference in prevalence of subjective symptoms of hearing impairment compared to objective (apparatus based and laboratory based) signs of hearing impairment

To analyse demographic data in conscripts with hearing impairment

To assess the prevalence of long-COVID in conscripts at the military induction board

To assess different symptoms of long-COVID in conscripts at the military induction board

To assess the prevalence of previous COVID 19 infections in conscripts at the military induction board

To analyse demographic data in conscripts with long-COVID

Medical University of Graz

Neoplasms

Carcinoma

Carcinoma, Squamous Cell

Head and Neck Neoplasms

Neoplasms, Glandular and Epithelial

Neoplasms by Histologic Type

Neoplasms, Squamous Cell

Antineoplastic Agents

All Drugs and Chemicals

Amino Acids

Erlotinib Hydrochloride

Tyrosine Kinase Inhibitors

Protein Kinase Inhibitors

Enzyme Inhibitors

Tyrosine

Tarceva will be administered at dosage 150 mg od one hour before or two hours after meat. Patients will receive Tarceva between 18 and 28 days.

Tarceva

Jean Pierre Delord, Docteur

The purpose of this study is to evaluate the biological effect of Tarceva (OSI-774) from an inhibition of EGF tumor receptor tyrosine kinase activity's point of view, for patients who are carriers of head and neck epidermoid carcinoma.

Patients will receive Tarceva in continuous between 18 and 28 days after pan-endoscopy exam until surgery

Study of Biological Effect of Tarceva (OSI-774) for Patients Stricken by ENT Epidermoid Carcinoma

Pilot Study, Without Direct Individual Benefice, of Biological Effect of Tarceva (OSI-774) at Posology of 150 mg by Day for Patients Stricken by ENT Epidermoid Carcinoma Waiting for First Surgical Picking up.

Study title	NCT ID	Conditions	Interventions	Eligibility	Organization	Link
Prevalence of ENT Diseseas	NCT06105346	Conscripts Military Induct... ENT Disease Rhinosinusitis ... Rhinosinusitis HPV Infection HPV Vaccine Long COVID ENT Surgery		17 Years - 19 Years	Medical University of Graz
Study of Biological Effect of Tarceva (OSI-774) for Patients Stricken by ENT Epidermoid Carcinoma	NCT00144976	Head and Neck N...	Tarceva	18 Years -	Institut Claudius Regaud

Spots Global Cancer Trial Database for ent

Every month we try and update this database with for ent cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.

Spots Global Cancer Trial Database for ent

Every month we try and update this database with for ent cancer trials from around the world to help patients and their families find trials that might be right for them. We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.

Every month we try and update this database with for ent cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.